Blog | Veristat Insights

Flexibility is the Key to Data Acquisition for Rare Disease Trials

March 27, 2018

Understanding Why Creative Solutions Are Necessary

With last month’s celebration of Rare Disease Month and specifically, Rare Disease Day, awareness of the research challenges faced by patients and pharma companies are especially high during this season.

Read More

Painting in the Dark | A Shift to Quarterly Conversations for Improving Employee Engagement

March 21, 2018

Have you ever tried to paint a room in the dark? Probably not, right? 

Why would anyone go through the trouble of getting the supplies and putting in the effort to attempt a job well done if they couldn’t see their progress along the way?  Just the same, why would anyone turn their career over to the annual performance review process? 

Read More

Join Veristat To Support Rare Cancer Research

January 10, 2018

CYCLE FOR SURVIVAL 2018

Every dollar represents hope, strength, and a lasting impact!

Read More

Fight Or Flight:  Reflections on Veristat's Light The Night Experience

October 27, 2017

If you heard the phrase, “You have cancer,” what would be your response?

Read More

Competing Risk Analysis in Clinical Trials | A Practical Example

October 3, 2017

In pharmaceutical clinical trials, considering competing risk analyses is highly important. Competing risks are events that may occur and prevent the evaluation of a specific primary endpoint, in turn biasing risk estimations or drug efficacy. 

Read More

Veristat Launches New eTMF System

August 15, 2017

To Improve Real-Time Visibility of Clinical Trial Documentation and Inspection-Readiness

Veristat has completed the validation and configuration of Master Control’s eTMF system, which is now implemented and available for Veristat managed clinical trials. 

Read More

Celebrating The Success of Velcade | 14 Years Later

August 3, 2017

Last week, Veristat attended the Massachusetts Biotechnology Council (MassBio) forum titled “Evolution of an Academic Discovery: First Person Account of the Development of Velcade®”.   

Read More

Veristat Participates in Cycle for Survival 2017 and Raises over $25,000 to Fund Rare Cancer Research

February 23, 2017

On Saturday, February 4, Team Veristat joined the battle against rare cancers at the 2017 Cycle for Survival event! Team Veristat had 14 riders at the Boston, MA event, including 2 colleagues from our UK office.  Our team surpassed our goal of raising over $25,000 to fund rare cancer research!

Read More

Be a Trusted Friend

January 5, 2017

For anyone who follows this blog with even moderate consistency, it is probably clear that Veristat is a growing organization.  It is hopefully just as apparent that we are a group who tremendously values and fiercely protects our culture. 

Read More

How Do You Make Informed Decisions about Implementing Adaptive Designs?

December 15, 2016

Read more about this and the discussions that you missed at the MassBio Forum on Adaptive Designs in Clinical Research that took place last month.

Read More